Subscribe to:
•
POZ magazine
•
E-newsletters
Visit:
•
African American
•
Women
POZ Personals
Sign In /
Join
Username:
Password:
HOME
ABOUT HIV/AIDS
What is HIV/AIDS?
Symptoms
Opportunistic Infections (OIs)
Newly Diagnosed
Disclosing Your HIV Status
Living With HIV
The Big Treatment Questions
Side Effects and Other Health Problems
POZ Focus / Fact Sheets
Finding a Doctor
Finding Support
Health Services Directory
PREVENTION
How is HIV Transmitted?
Health Services Directory
Getting Tested
Condoms
Safer Sex
Safer Injecting
TREATMENT
Drugs
Check Your Meds
Graph Your Labs
Lessons
POZ Focus / Fact Sheets
Webtorials
Treatment News
Conference Coverage
Health Services Directory
NEWS
Top Stories
Treatment News
RSS Feeds
Web Exclusives
Conference Coverage
POZ TV
World AIDS Day
COMMUNITY
Blogs
Forums
Personals
Polls
Surveys
Calendar
Bookstore
Mentors
Job Listings
African-American
Women
Latino
Community
Advocacy
ABOUT US
Who We Are
Our Staff
Advisory Board
Advertise
Awards
Press
Subscribe
Get Our E-Newsletter
Contact Us
EN ESPAÑOL
¿Recién te enteraste?
Recien Diagnosticados
Directorio De Servicios
POZ Focus Español
Amigos POZ
Lecciones
Medicamentos
Blog
Foros
POZ MAGAZINE
Subscribe
Current Issue
Archives
Bookstore
Latino Hub News
Back to home
» News & Views » Treatment News
July 31, 2009
Isentress Without a Protease Inhibitor Is Effective for Treatment Experienced Patients
South African Study: Nurses Comparable to Doctors in Monitoring HIV Management
July 30, 2009
Acyclovir Slows HIV Disease Progression, But Fails to Reduce HIV Transmission
Perhaps More Lipodystrophy With Sustiva?
July 29, 2009
High Prevalence of Vitamin D Deficiency in HIV-Positive Men
July 28, 2009
Once- vs. Twice-Daily Kaletra for Treatment Veterans
Menopause May Occur Earlier in HIV-Positive Women
Antidepressants May Be Helpful With Fatigue
July 27, 2009
Two Studies Explore Switch to Boosted Prezista Monotherapy
Switch From Norvir-Boosted to Unboosted Reyataz Safe and Effective
Chronic Stress and Non-AIDS Diseases—Is There a Link?
July 24, 2009
Kaletra Is Better Than Viramune for Kids Exposed to Viramune at Birth
Study Hints That Micronutrient Supplement Might Help HIV-Positive Kids
A Quad NRTI Regimen Fails to Perform
No Transmission and Few Birth Defects in Babies Born to African Mothers on HIV Treatment
July 23, 2009
HIV Treatment Effective Without Laboratory Monitoring in Southern Africa Study
Viramune Has Similar Efficacy to Reyataz
Zinc Supplements Prevent Immune Decline in Chronic Substance Users
Efavirenz, Race Linked to Vitamin D Deficiency
Cancer Rates Are Lower, but Still Present at Higher CD4 Levels
More Than Half of People With HIV Might Have Cognitive Impairment
July 22, 2009
Pediatric Viramune May Still Work as Treatment in Kids Exposed at Birth
Triple-Drug Regimen Works Well for Heavily Treatment-Experienced Patients
Efavirenz Five-Days-On, Two-Off, Works as Well as Continuous Treatment
ARV Therapy of Little Benefit in Preventing Anal Cancer
ARV Treatment Eases Cape Town TB Rates
People on Sustiva Have Less Risk for Treatment Failure Than People on Kaletra
Mma Bana: Lowest-Ever Mother-to-Child HIV Transmission Rates With Combo Therapy in Botswana
Substantial Single-Year Gains in ARV Access in 2008
July 21, 2009
Selzentry Comparable to Sustiva After 96 Weeks in Treatment Naives
Isentress Going Strong After Three Years in Treatment Starters
Circumcision Protects Insertive MSM Partners
More Than Half Could Need Treatment Within 2 Years of Infection
ARV Treatment Protects Against Malaria in Ugandan Study
Shionogi-GSK Integrase Inhibitor Shows Promise
July 20, 2009
Pediatric HIV: Successes and Challenges
GRACE Shows Similar Treatment Response Rates in Women and Men on Prezista Treatment
CD4 Counts Key to AIDS-Free Survival While on HIV Treatment
July 17, 2009
Gilead and Tibotec Partner to Produce AIDS Drug
Vicriviroc Trial in Treatment Newbies Gets OK to Continue
July 16, 2009
Early HIV Treatment Helps Acute Hep C Treatment Response
July 15, 2009
GSK Announces $80 Million to Prevent and Treat Pediatric HIV
July 14, 2009
Why Women and Men Have Differences in Disease Progression
July 13, 2009
Hep C Doubles Risk for AIDS Illnesses
July 10, 2009
Isentress Gets FDA Approval for Treatment Newbies
July 09, 2009
HIV Ravages Antibody-Producing Cells Days After Infection
July 08, 2009
Abbott Wins Appeal on Norvir Antitrust Case
July 07, 2009
Gradual Efavirenz Dosing Shows Promise
July 06, 2009
Effects of Race and Ethnicity on HIV Medication Adherence
July 02, 2009
Post-Menopausal Women Do Well on HIV Therapy
July 01, 2009
Unexpected Finding: Penetration of ARVs Into Nervous System Doesn’t Protect the Brain
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
Featured Video
Get Answers
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado
How to find a support system
Cómo encontrar un sistema de apoyo
Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento
How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud
How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
Personals
Forums
Blogs
POZ TV
[an error occurred while processing this directive]
[
about Smart + Strong
|
about POZ
|
POZ advisory board
|
partner links
|
advertising policy
|
advertise/contact us
|
site map
]
© 2010
Smart + Strong.
All Rights Reserved.
Terms of use
and
Your privacy